Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$0.54 - $1.41 $8,844 - $23,094
-16,379 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$1.4 - $5.15 $1,611 - $5,927
-1,151 Reduced 6.57%
16,379 $24,000
Q4 2021

Feb 11, 2022

SELL
$4.27 - $6.97 $2,246 - $3,666
-526 Reduced 2.91%
17,530 $92,000
Q3 2021

Nov 12, 2021

SELL
$5.31 - $8.25 $2,272 - $3,531
-428 Reduced 2.32%
18,056 $105,000
Q2 2021

Aug 13, 2021

SELL
$6.81 - $9.23 $4,392 - $5,953
-645 Reduced 3.37%
18,484 $149,000
Q1 2021

May 07, 2021

BUY
$7.99 - $15.0 $6,655 - $12,495
833 Added 4.55%
19,129 $159,000
Q4 2020

Feb 12, 2021

SELL
$7.04 - $11.7 $2,119 - $3,521
-301 Reduced 1.62%
18,296 $139,000
Q3 2020

Nov 04, 2020

SELL
$9.98 - $18.04 $568 - $1,028
-57 Reduced 0.31%
18,597 $198,000
Q2 2020

Aug 12, 2020

BUY
$7.49 - $15.16 $18,777 - $38,006
2,507 Added 15.53%
18,654 $283,000
Q1 2020

May 04, 2020

SELL
$4.62 - $18.74 $4,310 - $17,484
-933 Reduced 5.46%
16,147 $135,000
Q4 2019

Feb 05, 2020

SELL
$14.6 - $18.13 $2,087 - $2,592
-143 Reduced 0.83%
17,080 $289,000
Q3 2019

Nov 08, 2019

SELL
$16.62 - $23.92 $1,994 - $2,870
-120 Reduced 0.69%
17,223 $320,000
Q2 2019

Aug 13, 2019

BUY
$17.79 - $22.88 $12,791 - $16,450
719 Added 4.33%
17,343 $397,000
Q1 2019

May 06, 2019

SELL
$11.76 - $22.15 $6,326 - $11,916
-538 Reduced 3.13%
16,624 $349,000
Q4 2018

Feb 13, 2019

SELL
$10.42 - $21.94 $1,385 - $2,918
-133 Reduced 0.77%
17,162 $197,000
Q3 2018

Nov 09, 2018

BUY
$20.4 - $24.6 $6,385 - $7,699
313 Added 1.84%
17,295 $397,000
Q2 2018

Aug 08, 2018

BUY
$19.02 - $24.95 $2,681 - $3,517
141 Added 0.84%
16,982 $379,000
Q1 2018

May 07, 2018

SELL
$22.55 - $29.9 $16,010 - $21,229
-710 Reduced 4.05%
16,841 $385,000
Q4 2017

Feb 09, 2018

BUY
$18.0 - $30.0 $1,494 - $2,490
83 Added 0.48%
17,551 $460,000
Q3 2017

Nov 09, 2017

BUY
$21.1 - $25.15 $368,574 - $439,320
17,468
17,468 $392,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $116M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.